drug

artemether and lumefantrine

1 story · latest Jul 21, 2026

Status: FDA approved Apr 2009 · NDA022268
Brand: Coartem

Relationships

Developed by Novartis

Timeline

Novartis posts ASSIST Phase 2 results; two pediatric studies listed

Jul 21Weekly roundup, 3 itemsatrasentan coartem baby

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.